Sentinel Lymph Node Biopsy for Local Recurrence of Breast Cancer After Breast-Conserving Therapy

Taback, Bret; Nguyen, Phong; Hansen, Nora M.; Edwards, G K; Conway, Kim; Giuliano, Armando E.

doi:10.1245/aso.2006.08.026

Cited by 105 publications

(28 citation statements)

References 50 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…None of the patients had a positive sentinel lymph node and none have developed axillary recurrence, with follow-up ranging from 7 to 102 months. This report supports attempting sentinel lymph node biopsy in this group of patients but in conjunction with lymphoscintigraphy [12]. Additional reports have been published from Memorial Sloan Kettering Cancer Center [13], the European Institute of Oncology [14], Continuum Cancer Centers of New York [15], and The Netherlands Cancer Institute [16•] (Table 2).…”

Section: Sentinel Lymph Node Biopsy For Recurrent Breast Cancersupporting

confidence: 70%

“…In comparing reoperative sentinel lymph node biopsy after prior sentinel lymph node biopsy to prior axillary node dissection, the success rate after prior axillary node dissection is lower, ranging from 29% to 75% [3, 6, 11, 12, 16•, 19]. In addition, the frequency of aberrant drainage is also higher, ranging from 29% to 70% [6,11,12,15,19].…”

Section: Sentinel Lymph Node Biopsy For Recurrent Breast Cancermentioning

confidence: 99%

See 1 more Smart Citation

Reoperative Sentinel Lymph Node Surgery

Sbaity

Jacobs

2011

Curr Breast Cancer Rep

View full text Add to dashboard Cite

The role of sentinel lymph node biopsy for staging of primary breast cancer is well established. However, in cases of previous surgery to the breast or axilla, the reliability of sentinel lymph node biopsy has not been well established. Reoperative sentinel lymph node biopsy potentially has the same benefits as sentinel lymph node biopsy done at the time of the primary diagnosis, including staging, identifying at-risk lymph nodes, and providing critical information for use in treatment decision making. This article reviews the literature regarding reoperative sentinel lymph node biopsy and makes recommendations for implementation of the technology in this setting.

show abstract

Section: Sentinel Lymph Node Biopsy For Recurrent Breast Cancersupporting

confidence: 70%

Section: Sentinel Lymph Node Biopsy For Recurrent Breast Cancermentioning

confidence: 99%

Reoperative Sentinel Lymph Node Surgery

Sbaity

Jacobs

2011

Curr Breast Cancer Rep

View full text Add to dashboard Cite

show abstract

“…Our literature research totalizes 523 patients in 17 different studies, which included between 2 and 117 patients each (Table 1) [9,[11][12][13][14][15][16][17][18][19][20][21][22][23][24][25][26]. Overall SN was succesfully detected in 365/523 patients (70%).…”

Section: Resultsmentioning

confidence: 99%

“…In the study of Port et al, 53 patients with failed second SLNB 29 had no further additional nodes and one patient out of 24 ALND (1-26 further nodes) had a metastatic lymph node [9]. Secondary ALND after a previous ALND is able to remove 0 -16 further lymph nodes [12,16,18,20].…”

Section: What Should Be the Next Step For Patientsmentioning

confidence: 99%

Axillary Sentinel Lymph Node Biopsy for Breast Cancer and Melanoma Patients after Previous Axillary Surgery: A Systematic Review

Matter¹,

Romy²,

Boubaker³

et al. 2013

JCT

View full text Add to dashboard Cite

Objective: Sentinel lymph node biopsy (SLNB) is a validated staging technique for breast carcinoma. Some women are exposed to have a second SLNB due to breast cancer recurrence or a second neoplasia (breast or other). Due to modified anatomy, it has been claimed that previous axillary surgery represents a contra-indication to SLNB. Our objective was to analyse the literature to assess if a second SLNB is to be recommended or not. Methods: For the present study, we performed a review of all published data during the last 10 years on patients with previous axilla surgery and second SLNB. Results: Our analysis shows that second SLNB is feasible in 70%. Extra-axillary SNs rate (31%) was higher after radical lymph node dissection (ALND) (60% -84%) than after SLNB alone (14% -65%). Follow-up and complementary ALND following negative and positive second SLNB shows that it is a reliable procedure. Conclusion: The review of literature confirms that SLNB is feasible after previous axillary dissection. Triple technique for SN mapping is the best examination to highlight modified lymphatic anatomy and shows definitively where SLNB must be performed. Surgery may be more demanding as patients may have more frequently extra-axillary SN only, like internal mammary nodes. ALND can be avoided when second SLNB harvests negative SNs. These conclusions should however be taken with caution because of the heterogeneity of publications regarding SLNB and surgical technique.

show abstract

“…[4][5][6][7] Moreover, several studies have shown the feasibility of reoperative SLNB for patients with IBTR. [8][9][10][11][12][13][14] The present patient underwent reoperative SLNB for IBTR following previous BCT with axillary lymph node dissection (ALND). This procedure enabled the identifi cation of subclinical, harbored nodal metastasis.…”

Section: Introductionmentioning

confidence: 99%

Reoperative sentinel lymph node biopsy for ipsilateral breast tumor recurrence after previous axillary lymph node dissection: Report of a case

et al. 2011

View full text Add to dashboard Cite

Sentinel lymph node biopsy has become a standard component of the evaluation of early-stage breast cancer, with a gradually increasing number of indications in this patient population. This report presents the case of a patient who underwent reoperative sentinel lymph node biopsy as part of an evaluation of ipsilateral breast tumor recurrence; she had previously undergone axillary lymph node dissection. Preoperative lymphoscintigraphy showed aberrant lymphatic drainage, and all three sentinel lymph nodes were positive for cancer. Although the optimal management of regional lymph nodes in patients with ipsilateral breast tumor recurrence who have already undergone axillary lymph node dissection has not been established, reoperative sentinel lymph node biopsy in this setting may therefore potentially enable the identification of subclinical, aberrantly located nodal metastasis.

show abstract

Sentinel Lymph Node Biopsy for Local Recurrence of Breast Cancer After Breast-Conserving Therapy

Cited by 105 publications

References 50 publications

Reoperative Sentinel Lymph Node Surgery

Reoperative Sentinel Lymph Node Surgery

Axillary Sentinel Lymph Node Biopsy for Breast Cancer and Melanoma Patients after Previous Axillary Surgery: A Systematic Review

Reoperative sentinel lymph node biopsy for ipsilateral breast tumor recurrence after previous axillary lymph node dissection: Report of a case

Contact Info

Product

Resources

About